Your browser doesn't support javascript.
loading
Survival benefit of solid-organ transplant in the United States.
Rana, Abbas; Gruessner, Angelika; Agopian, Vatche G; Khalpey, Zain; Riaz, Irbaz B; Kaplan, Bruce; Halazun, Karim J; Busuttil, Ronald W; Gruessner, Rainer W G.
Afiliación
  • Rana A; Division of Abdominal Transplantation, Department of Surgery, Baylor College of Medicine, Houston, Texas.
  • Gruessner A; Division of Abdominal Transplantation, Department of Surgery, University of Arizona, Tucson.
  • Agopian VG; Dumont-UCLA Transplant and Liver Center, Department of Surgery, University of California, Los Angeles.
  • Khalpey Z; Division of Cardiothoracic Surgery, Department of Surgery, University of Arizona, Tucson.
  • Riaz IB; Department of Internal Medicine, University of Arizona, Tucson.
  • Kaplan B; Division of Nephrology, Department of Medicine, University of Arizona, Tucson.
  • Halazun KJ; Division of Transplantation, Department of Surgery, Emory University School of Medicine, Atlanta, Georgia.
  • Busuttil RW; Dumont-UCLA Transplant and Liver Center, Department of Surgery, University of California, Los Angeles.
  • Gruessner RW; Division of Abdominal Transplantation, Department of Surgery, University of Arizona, Tucson.
JAMA Surg ; 150(3): 252-9, 2015 Mar 01.
Article en En | MEDLINE | ID: mdl-25629390
ABSTRACT
IMPORTANCE The field of transplantation has made tremendous progress since the first successful kidney transplant in 1954.

OBJECTIVE:

To determine the survival benefit of solid-organ transplant as recorded during a 25-year study period in the United Network for Organ Sharing (UNOS) database and the Social Security Administration Death Master File. DESIGN, SETTING, AND

PARTICIPANTS:

In this retrospective analysis of UNOS data for solid-organ transplant during a 25-year period (September 1, 1987, through December 31, 2012), we reviewed the records of 1,112,835 patients 533,329 recipients who underwent a transplant and 579 506 patients who were placed on the waiting list but did not undergo a transplant. MAIN OUTCOMES AND

MEASURES:

The primary outcome was patient death while on the waiting list or after transplant. Kaplan-Meier survival functions were used for time-to-event analysis.

RESULTS:

We found that 2,270,859 life-years (2,150,200 life-years from the matched analysis) were saved to date during the 25 years of solid-organ transplant. A mean of 4.3 life-years were saved (observed to date) per solid-organ transplant recipient. Kidney transplant saved 1,372,969 life-years; liver transplant, 465,296 life-years; heart transplant, 269,715 life-years; lung transplant, 64,575 life-years; pancreas-kidney transplant, 79,198 life-years; pancreas transplant, 14,903 life-years; and intestine transplant, 4402 life-years. CONCLUSIONS AND RELEVANCE Our analysis demonstrated that more than 2 million life-years were saved to date by solid-organ transplants during a 25-year study period. Transplants should be supported and organ donation encouraged.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Obtención de Tejidos y Órganos / Sistema de Registros / Trasplante de Órganos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Humans País/Región como asunto: America do norte Idioma: En Revista: JAMA Surg Año: 2015 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Obtención de Tejidos y Órganos / Sistema de Registros / Trasplante de Órganos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Humans País/Región como asunto: America do norte Idioma: En Revista: JAMA Surg Año: 2015 Tipo del documento: Article